Kate is an accomplished digital transformation leader with 20+ years of experience in shaping digital marketing and digital innovation strategies and solutions for the life science industry, with the goal of enabling quantifiable business impact and delivering meaningful customer value. Her broad experience across pharmaceutical clients and therapeutic categories, and her combined agency and consulting background, has yielded a deep understanding of the innovation landscape, and how unique customer and category dynamics impact strategic planning and delivery.
Since joining Evolution Road in 2008, Kate has played an integral role in identifying the levers that dramatically increase business-driving potential of digital and emerging channels. She is passionate about translating innovative solutions and concepts into commercially viable strategies with demonstrated impact and repeatable learnings.
Evolution Road’s 22nd Holiday Dinner | Being Thankful
In December, we held our 22nd Holiday Dinner, and had a blast! We held a Rock ‘n Roll Happy Hour to celebrate, enjoyed classic rock trivia, name that tune and even co-created a song with everyone helping with the tune and the lyrics (of course we had professional help here). Unfortunately, we weren’t able to be together in person, but fortunately, we were able to have a lot of fun virtually and spend time with each other, and all our families, together. It warmed my heart, and I am so thankful we had the chance to celebrate together.
January 12, 2022
Kate Miller Named Chief Strategy Officer at Evolution Road
Kate Miller has been promoted to the position of Chief Strategy Officer from the position of Digital Innovation/Commercialization Practice Lead. She has been with the firm for nearly 14 years and was previously the Vice President of Strategy. Kate will be responsible for ER’s market vision, positioning and branding, thought leadership and intellectual property.
August 30, 2021
Announcing Decoding Digital Health for Life Sciences
The ER team is pleased to invite you to a new industry event called Decoding Digital Health for Life Sciences, running June 15-16, 2021. This event will help Life Science brand and commercial teams better understand the digital health opportunity and how to leverage digital health to improve patient outcomes and drive commercial success. Decoding Digital Health was co-created by Evolution Road and ER's own Paul Ivans & Todd Kolm are the conference co-chairs.
April 20, 2021
Using big data to boost engagement, conversion and revenue
One of the country’s largest pharmaceutical companies and a top health information technology company had always wanted to work together, yet the right opportunity never presented itself. Taking an independent, objective view, we found one driven by data.
With the objective of driving awareness and education across an entire portfolio and, ultimately, incremental treatment rates and improved patient outcomes, we layered multiple data sources to inform a multi-pronged digital communications strategy that reached three million patients and drove $40 million in incremental revenue.
March 23, 2021
Reimagining patient engagement
A multinational pharmaceutical manufacturer knew there was room to improve engagement and adherence amongst its diabetes patients.
Where standard approaches fell short, we created the digital strategy, guided program development and piloted a multi-touch engagement program designed to meet patients on their terms—with deep personalization and less friction.
March 23, 2021
Eliminating care gaps through digital innovation
One of the world’s top pharmaceutical companies sought to narrow gaps in care across its entire vaccine portfolio.
Cultivating a collaborative partnership for our client with CareSpeak, an OptimizeRx company that offers an interactive health messaging platform, we crafted a comprehensive member communications strategy that sparked measurable, meaningful engagement.
March 22, 2021
Telemedicine is here to stay: How the barriers are breaking down
Historically, telemedicine has been impeded by three main barriers: applicability, lack of insurance coverage, and technology. However, with COVID and innovation as accelerators, telemedicine is breaking through.
February 3, 2021